2012 年的 2 型糖尿病：T2DM 的最佳管理仍难以捉摸。
Type 2 diabetes mellitus in 2012: Optimal management of T2DM remains elusive.
机构信息
Diabetes Trials Unit, The Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Headington, UK.
出版信息
Nat Rev Endocrinol. 2013 Feb;9(2):67-8. doi: 10.1038/nrendo.2012.243. Epub 2013 Jan 8.
PMID:23296166
Abstract
Worldwide, >366 million people with type 2 diabetes mellitus remain at excess risk of cardiovascular disease and face a lifetime of treatment escalation for this progressive disorder. Studies in 2012 have re-affirmed the safety of early insulin treatment, metformin use in renal impairment, and shown β-cell function preservation over several years.
摘要
全球范围内，超过 3.66 亿 2 型糖尿病患者仍然面临心血管疾病的风险增加，并且这种进行性疾病需要终身治疗升级。2012 年的研究再次证实了早期胰岛素治疗的安全性、肾功能损害时使用二甲双胍的安全性，并显示出多年来对β细胞功能的保护作用。
Zotero 插件